Medistim Financial Statements From 2010 to 2024
| MEDI Stock | NOK 154.00 0.50 0.32% |
Check Medistim ASA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medistim ASA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Medistim financial statements analysis is a perfect complement when working with Medistim ASA Valuation or Volatility modules.
Medistim |
Medistim ASA Company Return On Asset Analysis
Medistim ASA's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medistim ASA Return On Asset | 0.2 |
Most of Medistim ASA's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medistim ASA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Medistim ASA has a Return On Asset of 0.1953. This is 102.23% lower than that of the Healthcare sector and 101.08% lower than that of the Medical Devices industry. The return on asset for all Norway stocks is notably lower than that of the firm.
Medistim ASA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medistim ASA's current stock value. Our valuation model uses many indicators to compare Medistim ASA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medistim ASA competition to find correlations between indicators driving Medistim ASA's intrinsic value. More Info.Medistim ASA is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.63 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medistim ASA is roughly 1.59 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medistim ASA's earnings, one of the primary drivers of an investment's value.About Medistim ASA Financial Statements
Medistim ASA investors utilize fundamental indicators, such as revenue or net income, to predict how Medistim Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway. MEDISTIM ASA operates under Medical Equipment classification in Norway and is traded on Oslo Stock Exchange. It employs 105 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Medistim Stock
Medistim ASA financial ratios help investors to determine whether Medistim Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medistim with respect to the benefits of owning Medistim ASA security.